Sodha N - Search Results

1

Analysis by array CGH of genomic changes associated with the progression or relapse of Wilms' tumour.

Natrajan R, Little SE, Sodha N, Reis-Filho JS, Mackay A, Fenwick K, Ashworth A, Perlman EJ, Dome JS, Grundy PE, Pritchard-Jones K, Jones C. Natrajan R, et al. Among authors: sodha n. J Pathol. 2007 Jan;211(1):52-9. doi: 10.1002/path.2087. J Pathol. 2007. PMID: 17103382

2

A robust method for detecting CHK2/RAD53 mutations in genomic DNA.

Sodha N, Houlston RS, Williams R, Yuille MA, Mangion J, Eeles RA. Sodha N, et al. Hum Mutat. 2002 Feb;19(2):173-7. doi: 10.1002/humu.10031. Hum Mutat. 2002. PMID: 11793476

3

Screening hCHK2 for mutations.

Sodha N, Williams R, Mangion J, Bullock SL, Yuille MR, Eeles RA. Sodha N, et al. Science. 2000 Jul 21;289(5478):359. doi: 10.1126/science.289.5478.359a. Science. 2000. PMID: 10939935 No abstract available.

4

Analysis of Li-Fraumeni syndrome and Li-Fraumeni-like families for germline mutations in Bcl10.

Stone JG, Eeles RA, Sodha N, Murday V, Sheriden E, Houlston RS. Stone JG, et al. Among authors: sodha n. Cancer Lett. 1999 Dec 1;147(1-2):181-5. doi: 10.1016/s0304-3835(99)00291-8. Cancer Lett. 1999. PMID: 10660104

5

CHEK2 variants in susceptibility to breast cancer and evidence of retention of the wild type allele in tumours.

Sodha N, Bullock S, Taylor R, Mitchell G, Guertl-Lackner B, Williams RD, Bevan S, Bishop K, McGuire S, Houlston RS, Eeles RA. Sodha N, et al. Br J Cancer. 2002 Dec 2;87(12):1445-8. doi: 10.1038/sj.bjc.6600637. Br J Cancer. 2002. PMID: 12454775 Free PMC article.

6

Overexpression of RAD51 occurs in aggressive prostatic cancer.

Mitra A, Jameson C, Barbachano Y, Sanchez L, Kote-Jarai Z, Peock S, Sodha N, Bancroft E, Fletcher A, Cooper C, Easton D; IMPACT Steering Committee and IMPACT and EMBRACE Collaborators; Eeles R, Foster CS. Mitra A, et al. Among authors: sodha n. Histopathology. 2009 Dec;55(6):696-704. doi: 10.1111/j.1365-2559.2009.03448.x. Histopathology. 2009. PMID: 20002770 Free PMC article.

7

Analysis of familial male breast cancer for germline mutations in CHEK2.

Sodha N, Wilson C, Bullock SL, Phillimore H, Houlston RS, Eeles RA. Sodha N, et al. Cancer Lett. 2004 Nov 25;215(2):187-9. doi: 10.1016/j.canlet.2004.07.002. Cancer Lett. 2004. PMID: 15488637

8

Rare germ line CHEK2 variants identified in breast cancer families encode proteins that show impaired activation.

Sodha N, Mantoni TS, Tavtigian SV, Eeles R, Garrett MD. Sodha N, et al. Cancer Res. 2006 Sep 15;66(18):8966-70. doi: 10.1158/0008-5472.CAN-06-1990. Cancer Res. 2006. PMID: 16982735

9

Increasing evidence that germline mutations in CHEK2 do not cause Li-Fraumeni syndrome.

Sodha N, Houlston RS, Bullock S, Yuille MA, Chu C, Turner G, Eeles RA. Sodha N, et al. Hum Mutat. 2002 Dec;20(6):460-2. doi: 10.1002/humu.10136. Hum Mutat. 2002. PMID: 12442270 No abstract available.

10

Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations.

Meijers-Heijboer H, van den Ouweland A, Klijn J, Wasielewski M, de Snoo A, Oldenburg R, Hollestelle A, Houben M, Crepin E, van Veghel-Plandsoen M, Elstrodt F, van Duijn C, Bartels C, Meijers C, Schutte M, McGuffog L, Thompson D, Easton D, Sodha N, Seal S, Barfoot R, Mangion J, Chang-Claude J, Eccles D, Eeles R, Evans DG, Houlston R, Murday V, Narod S, Peretz T, Peto J, Phelan C, Zhang HX, Szabo C, Devilee P, Goldgar D, Futreal PA, Nathanson KL, Weber B, Rahman N, Stratton MR; CHEK2-Breast Cancer Consortium. Meijers-Heijboer H, et al. Among authors: sodha n. Nat Genet. 2002 May;31(1):55-9. doi: 10.1038/ng879. Epub 2002 Apr 22. Nat Genet. 2002. PMID: 11967536

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

133 results

Search Page

Filters